NCT04071223 2026-05-13Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL StudyNational Cancer Institute (NCI)Phase 2 Active not recruiting134 enrolled